Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VNDA
#3250
Vanda Pharmaceuticals Inc. - Common Stock
5.3
3
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.62%
Monthly Change
+1.72%
6 month change
-31.84%
Year Change
-3.62%
Previous Close
5.5
3
Open
5.3
3
Low
5.3
0
High
5.3
5
Volume
599
Markets
US Stock Market
Healthcare
Biotechnology
VNDA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
58.93 M
59.09 M
59.1 M
59.11 M
60.14 M
60.46 M
60.46 M
Valuation ratios
Enterprise value
158.71 M
197.92 M
224.87 M
436.48 M
361.5 M
314.15 M
271.22 M
Price to earnings ratio
-6.04
-4.14
-3.49
-2.36
-1.7
-1.32
-1.17
Price to sales ratio
1.33
1.35
1.38
2.41
1.88
1.69
1.49
Price to cash flow ratio
6.49
4.35
3.58
-4.75
-3.23
-2.56
-2.26
Price to book ratio
0.13
0.13
0.15
1.59
0.26
0.28
0.25
Enterprise value to EBITDA ratio
-2.98
-2.42
-2.2
-3.1
-2.46
-1.83
-1.58
Profitability ratios
Return on assets %
-0.05
-0.04
-0.04
-0.29
-0.11
-0.15
-0.15
Return on equity %
-0.06
-0.06
-0.05
-0.43
-0.17
-0.28
-0.28
Return on invested capital %
-26.18
-24.68
-20.59
-146.39
-61.55
-84.49
-84.49
Gross margin %
92.96
94.8
94.75
93.3
93.89
92.95
92.95
Operating margin %
-81.99
-73.21
-55.61
-70.53
-97.11
-126.28
-126.28
EBITDA margin %
-78.03
-69.38
-51.96
-57.75
-92.74
-121.82
-121.82
Net margin %
-58.94
-51.73
-40.15
-246.76
-93.91
-123.72
-123.72
Liquidity ratios
Quick ratio
3.91
3.23
3.1
2.38
2.15
1.6
1.6
Current ratio
3.93
3.25
3.12
2.39
2.16
1.61
1.61
Inventory turnover
1.93
1.26
1.45
1.97
1.78
2.11
2.11
Asset turnover
0.08
0.08
0.09
0.1
0.11
0.12
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.57
-0.26
-0.54
-0.5
-0.84
-0.52
-2.39
EBIT per share
-0.7
-0.65
-0.53
-0.68
-0.84
-1.06
-3.12
EBITDA per share
-0.67
-0.62
-0.49
-0.56
-0.81
-1.02
-2.88
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.91
1.37
1.18
1.44
0.91
0.93
0.93
Net current asset value per share
6.97
6.69
6.22
5.89
4.93
4.39
4.39
Tangible book value per share
8.74
8.24
6.04
3.57
2.79
1.78
1.78
Working capital per share
5.19
4.63
4.22
3.43
2.65
1.67
1.67
Book value per share
8.74
8.24
7.89
5.55
4.72
3.66
3.66
News
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates
Vanda Pharmaceuticals - Risks Rising, Rewards Dwindling - Why I'm Downgrading To Hold
Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA)
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates
Wall Street Analysts Predict a 105.03% Upside in Vanda (VNDA): Here's What You Should Know
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates
AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights
Micron and Palantir among market cap stock movers on Tuesday
Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline